BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9199260)

  • 1. Maximizing radiotracer delivery to experimental atherosclerotic lesions with high-dose, negative charge-modified Z2D3 antibody for immunoscintigraphic targeting.
    Narula J; Petrov A; Ditlow C; Pak KY; Chen FW; Khaw BA
    J Nucl Cardiol; 1997; 4(3):226-33. PubMed ID: 9199260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noninvasive localization of experimental atherosclerotic lesions with mouse/human chimeric Z2D3 F(ab')2 specific for the proliferating smooth muscle cells of human atheroma. Imaging with conventional and negative charge-modified antibody fragments.
    Narula J; Petrov A; Bianchi C; Ditlow CC; Lister BC; Dilley J; Pieslak I; Chen FW; Torchilin VP; Khaw BA
    Circulation; 1995 Aug; 92(3):474-84. PubMed ID: 7634463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gamma imaging of atherosclerotic lesions: the role of antibody affinity in in vivo target localization.
    Narula J; Petrov A; O'Donnell SM; Ditlow C; Pieslak I; Dilley J; Chen F; Khaw BA
    J Nucl Cardiol; 1996; 3(3):231-41. PubMed ID: 8805743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noninvasive detection of atherosclerotic lesions by 99mTc-based immunoscintigraphic targeting of proliferating smooth muscle cells.
    Narula J; Petrov A; Pak KY; Ditlow C; Chen F; Khaw BA
    Chest; 1997 Jun; 111(6):1684-90. PubMed ID: 9187194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noninvasive localization of human atherosclerotic lesions with indium 111-labeled monoclonal Z2D3 antibody specific for proliferating smooth muscle cells.
    Carrió I; Pieri PL; Narula J; Prat L; Riva P; Pedrini L; Pretolani E; Caruso G; Sarti G; Estorch M; Berná L; Riambau V; Matías-Guiu X; Pak C; Ditlow C; Chen F; Khaw BA
    J Nucl Cardiol; 1998; 5(6):551-7. PubMed ID: 9869476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging experimental atherosclerotic lesions in ApoE knockout mice: enhanced targeting with Z2D3-anti-DTPA bispecific antibody and 99mTc-labeled negatively charged polymers.
    Khaw BA; Tekabe Y; Johnson LL
    J Nucl Med; 2006 May; 47(5):868-76. PubMed ID: 16644758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiolabeled MDA2, an oxidation-specific, monoclonal antibody, identifies native atherosclerotic lesions in vivo.
    Tsimikas S; Palinski W; Halpern SE; Yeung DW; Curtiss LK; Witztum JL
    J Nucl Cardiol; 1999; 6(1 Pt 1):41-53. PubMed ID: 10070840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo targeting of acute myocardial infarction with negative-charge, polymer-modified antimyosin antibody: use of different cross-linkers.
    Narula J; Torchilin VP; Petrov A; Khaw S; Trubetskoy VS; O'Donnell SM; Nossiff ND; Khaw BA
    J Nucl Cardiol; 1995; 2(1):26-34. PubMed ID: 9420759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Z2D3 imaging: fringe or frontier?
    Strauss HW
    J Nucl Cardiol; 1998; 5(6):626-8. PubMed ID: 9869485
    [No Abstract]   [Full Text] [Related]  

  • 10. Smooth muscle cell proliferation index correlates with 111In-labeled antibody Z2D3 uptake in a transplant vasculopathy swine model.
    Jimenez J; Donahay T; Schofield L; Khaw BA; Johnson LL
    J Nucl Med; 2005 Mar; 46(3):514-9. PubMed ID: 15750167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting arterial wall sulfated glycosaminoglycans in rabbit atherosclerosis with a mouse/human chimeric antibody.
    Soto Y; Mesa N; Alfonso Y; Pérez A; Batlle F; Griñán T; Pino A; Viera J; Frómeta M; Brito V; Olivera A; Zayas F; Vázquez AM
    MAbs; 2014; 6(5):1340-6. PubMed ID: 25517318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Results of immunoscintigraphy using a cocktail of radiolabeled monoclonal antibodies in the detection of colorectal cancer.
    Volpe CM; Abdel-Nabi HH; Kulaylat MN; Doerr RJ
    Ann Surg Oncol; 1998 Sep; 5(6):489-94. PubMed ID: 9754756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [In vivo noninvasive detection of vulnerable atherosclerotic plaque by (99)Tc(m)-Annexin V imaging in an atherosclerotic rabbit model.].
    Xu JP; Zhao QM; Dong XL; Wang Q; Chen D; Mi HZ; DU HF; Xu ZM
    Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Oct; 36(10):921-6. PubMed ID: 19102893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting of apoptotic macrophages and experimental atheroma with radiolabeled annexin V: a technique with potential for noninvasive imaging of vulnerable plaque.
    Kolodgie FD; Petrov A; Virmani R; Narula N; Verjans JW; Weber DK; Hartung D; Steinmetz N; Vanderheyden JL; Vannan MA; Gold HK; Reutelingsperger CP; Hofstra L; Narula J
    Circulation; 2003 Dec; 108(25):3134-9. PubMed ID: 14676140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoscintigraphy of atherosclerotic uncomplicated lesions in vivo with a monoclonal antibody against D-dimers of insoluble fibrin.
    Ciavolella M; Tavolaro R; Taurino M; Di Loreto M; Greco C; Sbarigia E; Casini A; Speziale F; Scopinaro F
    Atherosclerosis; 1999 Mar; 143(1):171-5. PubMed ID: 10208492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preclinical evaluation of SPECT imaging with 131I-labeled monoclonal antibody SZ39 in nude mice bearing human glioma xenografts.
    Lan Q; Huang Q; Bao S
    J Neuroimaging; 1996 Apr; 6(2):131-5. PubMed ID: 8634489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pretargeting of carcinoembryonic antigen-expressing tumors with a biologically produced bispecific anticarcinoembryonic antigen x anti-indium-labeled diethylenetriaminepentaacetic acid antibody.
    van Schaijk FG; Oosterwijk E; Soede AC; Broekema M; Frielink C; McBride WJ; Goldenberg DM; Corstens FH; Boerman OC
    Clin Cancer Res; 2005 Oct; 11(19 Pt 2):7130s-7136s. PubMed ID: 16203812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and tumor targeting of 131I-labeled F(ab')2 fragments of the chimeric monoclonal antibody G250: preclinical and clinical pilot studies.
    Brouwers A; Mulders P; Oosterwijk E; Buijs W; Corstens F; Boerman O; Oyen W
    Cancer Biother Radiopharm; 2004 Aug; 19(4):466-77. PubMed ID: 15453961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biodistribution of anti-CEA F(ab')2 fragments conjugated with chelating polymers: influence of conjugate electron charge on tumor uptake and blood clearance.
    Slinkin MA; Curtet C; Faivre-Chauvet A; Sai-Maurel C; Gestin JF; Torchilin VP; Chatal JF
    Nucl Med Biol; 1993 May; 20(4):443-52. PubMed ID: 8504286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radioimmunotherapy of intracerebral human glioma xenografts with 131I-labeled F(ab')2 fragments of monoclonal antibody Mel-14.
    Colapinto EV; Zalutsky MR; Archer GE; Noska MA; Friedman HS; Carrel S; Bigner DD
    Cancer Res; 1990 Mar; 50(6):1822-7. PubMed ID: 2407345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.